S&T Bank’s AstraZeneca AZN Stock Holding History

S&T Bank’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-404	Closed	-$56.5K	–	487
2025 Q2	$56.5K	Hold	404	–	–	0.02%	158
2025 Q1	$59.4K	Buy	+404	New	+$58.5K	0.02%	152

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

S&T Bank's AZN Position: Q3 2025 in Review

S&T Bank sold out of AstraZeneca (AZN) in Q3 2025, closing a stake of 404 shares — an estimated $56.5K sold.

S&T Bank first reported a position in AZN in Q1 2025 and held it in 2 quarters. The position peaked at $59.4K in Q1 2025. 1,287 funds tracked by Wall St. Rank hold AZN as of Q3 2025.

S&T Bank reported no remaining AstraZeneca position as of Q3 2025 after selling out during the quarter.
S&T Bank sold 404 AstraZeneca shares in Q3 2025, an estimated $56.5K.
S&T Bank first reported a position in AstraZeneca in Q1 2025 and held it in 2 quarters.
S&T Bank's AstraZeneca position peaked at $59.4K in Q1 2025.
1,287 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2025.

Based on S&T Bank's 13F filing for Q3 2025, filed 14 Nov 2025.